ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.050,55
0,26%
S&P 500
5.917,11
0,00%
Dow Jones
43.408,47
0,00%
Euro vs US Dollar
1,0533
-0,12%
Bitcoin
97.393,99
3,22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:AZN
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202417h00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
19/11/202416h47Alliance NewsAlliance NewsAstraZeneca "disappointed" as breast cancer drug blocked for NHS useLSE:AZNAstrazeneca Plc
19/11/202416h47Alliance NewsAlliance NewsAstraZeneca "disappointed" as breast cancer drug blocked for NHS useLSE:AZNAstrazeneca Plc
18/11/202413h43Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buyLSE:AZNAstrazeneca Plc
18/11/202413h43Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buyLSE:AZNAstrazeneca Plc
18/11/202410h01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoLSE:AZNAstrazeneca Plc
18/11/202410h01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoLSE:AZNAstrazeneca Plc
18/11/202408h00RNS Regulatory NewsAstraZeneca PLC Tagrisso recommended for EU approval - LAURALSE:AZNAstrazeneca Plc
15/11/202415h00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
15/11/202412h04Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in sharesLSE:AZNAstrazeneca Plc
15/11/202412h04Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in sharesLSE:AZNAstrazeneca Plc
15/11/202411h00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
13/11/202417h00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
12/11/202420h50Alliance NewsAlliance NewsIN BRIEF: Merck trial shows Koselugo effective in treating adultsLSE:AZNAstrazeneca Plc
12/11/202420h50Alliance NewsAlliance NewsIN BRIEF: Merck trial shows Koselugo effective in treating adultsLSE:AZNAstrazeneca Plc
12/11/202413h21Alliance NewsAlliance NewsEXTRA: AstraZeneca results impress but China a likely short-term dragLSE:AZNAstrazeneca Plc
12/11/202413h21Alliance NewsAlliance NewsEXTRA: AstraZeneca results impress but China a likely short-term dragLSE:AZNAstrazeneca Plc
12/11/202409h59Alliance NewsAlliance NewsTOP NEWS: AstraZeneca lifts annual guidance despite possible forex hitLSE:AZNAstrazeneca Plc
12/11/202409h59Alliance NewsAlliance NewsTOP NEWS: AstraZeneca lifts annual guidance despite possible forex hitLSE:AZNAstrazeneca Plc
12/11/202408h10RNS Regulatory NewsAstraZeneca PLC AstraZeneca invests $3.5 billion in USLSE:AZNAstrazeneca Plc
12/11/202408h05RNS Regulatory NewsAstraZeneca PLC KOMET Phase III trial met primary endpointLSE:AZNAstrazeneca Plc
12/11/202408h00RNS Regulatory NewsAstraZeneca PLC 9M and Q3 2024 ResultsLSE:AZNAstrazeneca Plc
12/11/202408h00RNS Regulatory NewsAstraZeneca PLC Dato-DXd new BLA submitted, NSQ BLA withdrawnLSE:AZNAstrazeneca Plc
08/11/202410h13Alliance NewsAlliance NewsAstraZeneca touts positive results from nasal polyp treatment studyLSE:AZNAstrazeneca Plc
08/11/202410h13Alliance NewsAlliance NewsAstraZeneca touts positive results from nasal polyp treatment studyLSE:AZNAstrazeneca Plc
08/11/202408h00RNS Regulatory NewsAstraZeneca PLC Tezspire nasal polyps trial met primary endpointsLSE:AZNAstrazeneca Plc
07/11/202412h14Alliance NewsAlliance NewsTOP NEWS: AstraZeneca says China chief detained as under investigationLSE:AZNAstrazeneca Plc
07/11/202412h14Alliance NewsAlliance NewsTOP NEWS: AstraZeneca says China chief detained as under investigationLSE:AZNAstrazeneca Plc
05/11/202419h39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca pledges to assist in China probe as shares slideLSE:AZNAstrazeneca Plc
05/11/202419h39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca pledges to assist in China probe as shares slideLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Kürzlich von Ihnen besucht

TG
KP1
Kore Potash
NYSE
A
Agilent Technologies
USOTC
ABSKF
Abacus Storage King (PK)
USOTC
AWINW
AERWINS Technologies (CE)
LSE
AGYA
Allergy Therapeutics
NYSE
GDF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten